Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment

Novel continuous passive motion device for self-treatment of chronic lower back pain: a randomised controlled study.

Physiotherapy·2014

Antileishmanial activity in Israeli plants.

Annals of tropical medicine and parasitology·2009

Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2009

Alpha 2 macroglobulin activity in rats infected with Typanosoma lewisi and treated with cyclophosphamide and its effect on the malignancy of the disease.

Journal of vector borne diseases·2007

Pathological developments mediated by cyclophosphamide in rats infected with Trypanosoma lewisi.

Parasitology international·2006

The flow-cytometry-based evaluation of cellular immunity in cases of cutaneous leishmaniasis and healthy controls from the endemic area in southern Israel.

Annals of tropical medicine and parasitology·2006

Highlights from JAAD International: January 2027 - Dermatologic Care Delivery in Vietnam.

Journal of the American Academy of Dermatology·2026

Psoriasis: Which therapy for which patient, updated, part II. Focus on special populations and chronic infections.

Journal of the American Academy of Dermatology·2026

Efficacy and safety of QY201, an oral dual Janus kinase 1/tyrosine kinase 2 inhibitor, in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Journal of the American Academy of Dermatology·2026

Repeated malaria exposure reprograms Vδ2+ γδ T cell chromatin accessibility and immune function toward a reversible hyporesponsive state.

bioRxiv : the preprint server for biology·2026

Long-read sequencing reveals genomic landscape of structural variants in a major disease vector.

bioRxiv : the preprint server for biology·2026

AIM2 as a therapeutic target in autoimmunity: balancing inflammasome inhibition with immune homeostasis.

Autoimmunity reviews·2026

Development and validation of two multiplex PCR assays for the detection of mollusc parasites Bonamia ostreae, Bonamia exitiosa, Marteilia refringens and Marteilia pararefringens.

Journal of invertebrate pathology·2026

Genetic Modification Technologies and Microbial Interventions for Mosquito Control: Recent Advances in Biological Strategies Against Vector-Borne Diseases.

Journal of vector borne diseases·2026

Persistent Non-Falciparum Malaria in Kenya: Evidence from 17 Years of Sentinel Surveillance.

Military medicine·2026

Related Experiment Videos

Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment

Related Concept Videos

Novel continuous passive motion device for self-treatment of chronic lower back pain: a randomised controlled study.

Antileishmanial activity in Israeli plants.

Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes.

Alpha 2 macroglobulin activity in rats infected with Typanosoma lewisi and treated with cyclophosphamide and its effect on the malignancy of the disease.

Pathological developments mediated by cyclophosphamide in rats infected with Trypanosoma lewisi.

The flow-cytometry-based evaluation of cellular immunity in cases of cutaneous leishmaniasis and healthy controls from the endemic area in southern Israel.

Highlights from JAAD International: January 2027 - Dermatologic Care Delivery in Vietnam.

Psoriasis: Which therapy for which patient, updated, part II. Focus on special populations and chronic infections.

Efficacy and safety of QY201, an oral dual Janus kinase 1/tyrosine kinase 2 inhibitor, in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Repeated malaria exposure reprograms Vδ2+ γδ T cell chromatin accessibility and immune function toward a reversible hyporesponsive state.

Long-read sequencing reveals genomic landscape of structural variants in a major disease vector.

AIM2 as a therapeutic target in autoimmunity: balancing inflammasome inhibition with immune homeostasis.

Development and validation of two multiplex PCR assays for the detection of mollusc parasites Bonamia ostreae, Bonamia exitiosa, Marteilia refringens and Marteilia pararefringens.

Genetic Modification Technologies and Microbial Interventions for Mosquito Control: Recent Advances in Biological Strategies Against Vector-Borne Diseases.

Persistent Non-Falciparum Malaria in Kenya: Evidence from 17 Years of Sentinel Surveillance.

Related Experiment Videos

Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment

Related Concept Videos

Related Articles